Stäubli Robotics and Quantum Surgical, an innovative surgical robotic company, is developing an innovative solution, a combination of powerful software and robotic platform for minimally invasive therapies in liver cancer.
This strategic partnership aims to combine this “savoir-faire” to strengthen the role of robotics in minimally invasive cancer treatments and to build a “world leader”, according to the companies.
A memorandum of understanding has been signed by the two parties.
Gerald Vogt, CEO of Stäubli Robotics, says: “We are extremely grateful and proud that Quantum Surgical confirms their trust in Stäubli as a partner of choice for this new patient care application, at the service of human well-being.
“We are excited to contributing to Quantum’s vision together, with a long-term partner that stimulates us on a daily basis and makes us better.”
Bertin Nahum, president and founder of Quantum Surgical, says: “We are honored to work with Stäubli, a company recognized for its technological excellence and savoir-faire, in order to share a vision of robotics and automation in healthcare.”